Inventor
NIVAGGIOLI THIERRY
US48 patents
⚠️ This page may combine multiple inventors who share the name “NIVAGGIOLI THIERRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
17 patentsUS7771742B2Aug 10, 2010
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
ALLERGAN INC47 citations97
US8034366B2Oct 11, 2011
Ocular implant made by a double extrusion process
ALLERGAN INC32 citations96
US8034370B2Oct 11, 2011
Ocular implant made by a double extrusion process
ALLERGAN INC32 citations96
US9192511B2Nov 24, 2015
Ocular implant made by a double extrusion process
ALLERGAN INC10 citations92
US8048445B2Nov 1, 2011
Ocular implant made by a double extrusion process
ALLERGAN INC14 citations92
US8968766B2Mar 3, 2015
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
ALLERGAN INC19 citations91
US10702539B2Jul 7, 2020
Ocular implant made by a double extrusion process
ALLERGAN INC3 citations84
US10076526B2Sep 18, 2018
Ocular implant made by a double extrusion process
ALLERGAN INC6 citations84
US10076492B2Sep 18, 2018
Biodegradable intravitreal tyrosine kinase implants
ALLERGAN INC4 citations84
US9327059B2May 3, 2016
Steroid-containing sustained release intraocular implants and related methods
ALLERGAN INC8 citations84
US9233070B2Jan 12, 2016
Biodegradable intravitreal tyrosine kinase implants
ALLERGAN INC6 citations84
US10874605B2Dec 29, 2020
Extended release biodegradable ocular implants
ALLERGAN INC7 citations82
US10881608B2Jan 5, 2021
Biodegradable intravitreal tyrosine kinase implants
ALLERGAN INC1 citations73
US8974812B2Mar 10, 2015
Extended release biodegradable ocular implants
ALLERGAN INC3 citations63
US8895049B2Nov 25, 2014
Extended release biodegradable ocular implants
ALLERGAN INC1 citations63
US8778381B2Jul 15, 2014
Ocular implant made by a double extrusion process
ALLERGAN INC0 citations52
US10154960B2Dec 18, 2018
Extended release biodegradable ocular implants
ALLERGAN INC0 citations50
HUANG GLENN T
9 patentsUS8147865B2Apr 3, 2012
Steroid-containing sustained release intraocular implants and related methods
HUANG GLENN T44 citations98
US8119154B2Feb 21, 2012
Sustained release intraocular implants and related methods
HUANG GLENN T41 citations98
US8440216B2May 14, 2013
Sustained release intraocular implants and related methods
HUANG GLENN T29 citations96
US8298570B2Oct 30, 2012
Sustained release intraocular implants and related methods
HUANG GLENN T12 citations92
US8263110B2Sep 11, 2012
Sustained release intraocular implants and related methods
HUANG GLENN T13 citations92
US8257730B2Sep 4, 2012
Steroid-containing sustained release intraocular implants and related methods
HUANG GLENN T12 citations92
US8962009B2Feb 24, 2015
Sustained release intraocular implants and related methods
HUANG GLENN T6 citations84
US8771722B2Jul 8, 2014
Methods of treating ocular disease using steroid-containing sustained release intraocular implants
HUANG GLENN T8 citations84
US8715709B2May 6, 2014
Sustained release intraocular implants and methods for treating ocular neuropathies
HUANG GLENN T1 citations52
SANTEN PHARMACEUTICAL CO LTD
6 patentsUS8367097B2Feb 5, 2013
Liquid formulations for treatment of diseases or conditions
SANTEN PHARMACEUTICAL CO LTD31 citations95
US8927005B2Jan 6, 2015
Liquid formulations for treatment of diseases or conditions
SANTEN PHARMACEUTICAL CO LTD20 citations92
US9387165B2Jul 12, 2016
Rapamycin formulations and methods of their use
SANTEN PHARMACEUTICAL CO LTD3 citations72
US9381153B2Jul 5, 2016
Liquid formulations for treatment of diseases or conditions
SANTEN PHARMACEUTICAL CO LTD1 citations62
US8658667B2Feb 25, 2014
Stable formulations, and methods of their preparation and use
SANTEN PHARMACEUTICAL CO LTD2 citations59
US9452156B2Sep 27, 2016
Formulations and methods for vascular permeability-related diseases or conditions
SANTEN PHARMACEUTICAL CO LTD0 citations51